Daewon Pharm (003220) — Financial Flexibility Index
Daewon Pharm (003220) has a Financial Flexibility Index of 0.13x as of December 2025. Free cash flow of ₩43.69 Billion (operating CF ₩30.61 Billion minus capex ₩13.07 Billion) represents 0% of total liabilities (₩339.07 Billion). Also explore how fast is Daewon Pharm growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daewon Pharm Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Daewon Pharm across 15 annual periods. Check 003220 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Daewon Pharm (2011–2025)
Year-by-year free cash flow to debt coverage for Daewon Pharm. For the full company profile including market capitalisation, see Daewon Pharm (003220) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | ₩84.44 Billion | ₩42.31 Billion | ₩339.07 Billion | ▼ -11.0% |
| 2024 | 0.28x | ₩83.62 Billion | ₩30.04 Billion | ₩298.81 Billion | ▼ -5.7% |
| 2023 | 0.30x | ₩72.34 Billion | ₩51.73 Billion | ₩243.73 Billion | ▲ +30.2% |
| 2022 | 0.23x | ₩46.69 Billion | ₩33.33 Billion | ₩204.78 Billion | ▲ +81.6% |
| 2021 | 0.13x | ₩26.52 Billion | ₩22.41 Billion | ₩211.18 Billion | ▼ -57.6% |
| 2020 | 0.30x | ₩36.30 Billion | ₩24.95 Billion | ₩122.44 Billion | ▼ -42.9% |
| 2019 | 0.52x | ₩64.00 Billion | ₩30.97 Billion | ₩123.32 Billion | ▼ -40.8% |
| 2018 | 0.88x | ₩80.85 Billion | ₩40.03 Billion | ₩92.24 Billion | ▲ +172.9% |
| 2017 | 0.32x | ₩18.98 Billion | ₩4.27 Billion | ₩59.07 Billion | ▼ -59.1% |
| 2016 | 0.79x | ₩41.36 Billion | ₩20.79 Billion | ₩52.67 Billion | ▼ -20.7% |
| 2015 | 0.99x | ₩45.62 Billion | ₩25.82 Billion | ₩46.09 Billion | ▲ +37.1% |
| 2014 | 0.72x | ₩33.28 Billion | ₩17.45 Billion | ₩46.11 Billion | ▲ +20.1% |
| 2013 | 0.60x | ₩22.17 Billion | ₩12.32 Billion | ₩36.89 Billion | ▲ +20.0% |
| 2012 | 0.50x | ₩17.13 Billion | ₩13.83 Billion | ₩34.20 Billion | ▼ -35.0% |
| 2011 | 0.77x | ₩28.12 Billion | ₩17.93 Billion | ₩36.47 Billion | — |